<DOC>
	<DOCNO>NCT01514578</DOCNO>
	<brief_summary>This study evaluate safety , blood level , effect TRV130A pain perception sedation healthy adult male .</brief_summary>
	<brief_title>Single Ascending Dose Study Intravenous TRV130A Healthy Adult Males</brief_title>
	<detailed_description />
	<criteria>Healthy adult male 19 50 year age Body weight &gt; /= 50 kg Capable give write informed consent Clinically significant disease condition may place subject unacceptable risk participant study , may interfere safety , tolerability pharmacodynamic evaluation study Laboratory test positive HIV , Hepatitis B virus surface antigen , Hepatitis C virus antibody ; elevation aspartate aminotransferase alanine aminotransferase ; positive drug alcohol test ; positive urine test cotinine Major surgery within 4 week screen</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>TRV130A</keyword>
</DOC>